UK's Medical Cannabis Trial, Training Farmers And Medical Professionals In Morocco & More Global Updates

• U.S. Territory Passes Bill Ending Pre-Employment Marijuana Testing For Most Government Jobs

Lawmakers in the Commonwealth of the Northern Mariana Islands (CNMI) passed a bill to end pre-employment marijuana testing for most government jobs, with exemptions for safety-sensitive positions and jobs involving federal contracts. According to Marijuana Moment, the legislation is now heading to the Senate for consideration during a special session.

• Australia Considers Bill To Exempt Medicinal Cannabis Drivers From Prosecution

The New South Wales government is set to consider a bill that could exempt drivers with a medicinal cannabis prescription from prosecution if they test positive in a roadside drug test, with the NSW Legalise Cannabis Party proposing to treat medicinal cannabis like other legal medications for drivers, provided they are complying with their prescription and doctor's advice; however, those abusing their medication could still face impairment tests and potential prosecution under the proposed legislation, per 9 News.

• Belgian Start-Up To Research Cannabinoid Potential With $1.5M Funding

Belgian start-up CBX Medical, which already sells cannabis-based products in pharmacies, will conduct extensive research into the medical potential of cannabinoids, including lesser-known ones like CBC, CBL and CBD to develop new cannabinoid-based medicines in around 10 years, supported by a grant of €573,000 ($ 624,570) from the Walloon government and additional funding of €800,000 ($ 875,444), reported Brussels Times.

• UK NHS Approves Full-Scale Medical Cannabis Trial, Celadon Pharma Launches Canpain Study

The UK's National Health Service (NHS) Research Ethics Committee has approved a full-scale clinical trial on medical cannabis and non-cancer chronic pain, marking another positive development in the country's medical cannabis industry, which has seen significant growth in private prescriptions. Meanwhile, AIM-listed medical cannabis company Celadon Pharmaceuticals announced the approval for its subsidiary to launch its Canpain trial, aimed at developing new cannabinoid-based medicines with potential NHS reimbursement.

• Moroccan Cannabis Association Teams Up With American Company For Training Program

The Moroccan Consultative Association for the Use of Cannabis (AMCUC) has partnered with the American cannabis transformation company Advanced to provide comprehensive training to farmers and medical professionals on the legal medical and agricultural applications of cannabis. The marks the first-ever collaboration between an American industry giant and a Moroccan cannabis advisory association. The goal is to strengthen the association's "KIF TAKIWNE" project focused on scientific and technical training on cannabis derivatives and proper cultivation methods, to transform cannabis cultivation in Morocco through legalization.

• Price Action

Cambria Cannabis ETF TOKE is down 3.14% at about $6.01 a share.

Amplify Seymour Cannabis ETF CNBS is down 1.85%  to about $3.97 a share

AdvisorShares Pure Cannabis ETF YOLO is down 1.28% at about $2.6655.

ETFMG Alternative Harvest MJ is down 2.36 % at about $3.1636.

AXS Cannabis ETF THCX is down 5.16% at $1.821.

Global X Cannabis ETF POTX is down 2.13%, hovering at around $6.90.

• The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
• Photo: Courtesy Of Andrei Minsk and Marti Bug Catcher on Shutterstock Edited by Benzinga